An analysis of comparative trails of L-asparaginase (NSC-109929), cyclophosphamide and placebo in patients with inoperable bronchogenic carcinoma using corrected survival estimates.

Subjects

Subjects :

Adult
Asparaginase administration & dosage
Asparaginase adverse effects
Clinical Trials as Topic
Cyclophosphamide administration & dosage
Humans
Male
Placebos
Asparaginase therapeutic use
Carcinoma, Bronchogenic drug therapy
Cyclophosphamide therapeutic use
Lung Neoplasms drug therapy

Details

Language :

English

ISSN :

0030-2414

Volume :

35

Issue :

1

Database :

MEDLINE

Journal :

Oncology

Publication Type :

Academic Journal

Accession number :

343025

Full Text :

https://doi.org/10.1159/000225252